West Pharmaceutical Services, Inc. (FRA:WPS)
Germany flag Germany · Delayed Price · Currency is EUR
192.40
-3.20 (-1.64%)
At close: Jan 30, 2026

FRA:WPS Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
628.5484.6853.9894.3762.6615.5
Cash & Short-Term Investments
628.5484.6853.9894.3762.6615.5
Cash Growth
28.03%-43.25%-4.52%17.27%23.90%40.17%
Receivables
652.5575.8533.5523.7503.6385.3
Inventory
438377434.7414.8378.4321.3
Other Current Assets
104.3100.7114.386.797.451.6
Total Current Assets
1,8231,5381,9361,9201,7421,374
Property, Plant & Equipment
1,8741,7161,5131,2631,1271,012
Long-Term Investments
220.9202.1210204.9207.7214.7
Goodwill
110.6106108.5107.3109.9111.1
Other Intangible Assets
8.910.815.118.42330.5
Long-Term Accounts Receivable
-----10.9
Long-Term Deferred Tax Assets
27.92625.765.648.516
Long-Term Deferred Charges
-----0.4
Other Long-Term Assets
40.644.621.338.455.925
Total Assets
4,1063,6433,8303,6173,3142,794
Accounts Payable
255.8239.3242.4215.4232.2213.1
Accrued Expenses
111.8138161.3141.1186.1149.1
Current Portion of Long-Term Debt
--1342.244.22.3
Current Portion of Leases
22.918.817.7169.310.1
Current Income Taxes Payable
33.331.516.629.526.326
Current Unearned Revenue
-49.641.757.348.751
Other Current Liabilities
211.673.258.157.547.351.8
Total Current Liabilities
635.4550.4671.8519594.1503.4
Long-Term Debt
202.7202.672.8206.7208.8258.5
Long-Term Leases
77.483.984.5936360.4
Long-Term Unearned Revenue
-3.612.210.9--
Pension & Post-Retirement Benefits
31.128.229.628.240.557.5
Long-Term Deferred Tax Liabilities
22.820.512.714.34.910.4
Other Long-Term Liabilities
84.971.964.959.867.149.1
Total Liabilities
1,054961.1948.5931.9978.4939.3
Common Stock
18.818.818.818.818.818.8
Additional Paid-In Capital
-22.1120.2232.2249267.3
Retained Earnings
4,2623,9573,5232,9882,4571,847
Treasury Stock
-1,127-1,057-637.6-370.9-229.5-167.7
Comprehensive Income & Other
-102.3-258.1-143.8-183-159.6-110.6
Shareholders' Equity
3,0522,6822,8812,6852,3351,855
Total Liabilities & Equity
4,1063,6433,8303,6173,3142,794
Total Debt
303305.3309317.9325.3331.3
Net Cash (Debt)
325.5179.3544.9576.4437.3284.2
Net Cash Growth
77.87%-67.09%-5.46%31.81%53.87%162.18%
Net Cash Per Share
4.472.437.247.605.733.75
Filing Date Shares Outstanding
71.9472.373.374.1474.2874.1
Total Common Shares Outstanding
71.972.373.574.174.274.02
Working Capital
1,188987.71,2651,4011,148870.3
Book Value Per Share
42.4437.1039.2036.2331.4725.05
Tangible Book Value
2,9322,5662,7572,5592,2031,713
Tangible Book Value Per Share
40.7835.4837.5234.5429.6823.14
Land
-27.933.72929.324.8
Buildings
-916.1771.5663.6644.8618.1
Machinery
-1,6311,5181,3881,2981,201
Construction In Progress
-410.8415.2305.9242.7192.1
Source: S&P Global Market Intelligence. Standard template. Financial Sources.